TP53 mutation detected in circulating exosomal DNA is associated with prognosis of patients with hepatocellular carcinoma

Exosome DNA (exoDNA) can be used for liquid biopsy. This study was the first to use droplet digital PCR (ddPCR) to detect tumor-specific mutations in exoDNA and to evaluate the prognosis of hepatocellular carcinoma (HCC) patients. 60 HCC patients were enrolled in the study. We used ddPCR to detect c...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yong, Wu, Junjun, Li, Enliang, Xiao, Zhouqing, Lei, Jun, Zhou, Fan, Yin, Xiangbao, Hu, Dandan, Mao, Yilei, Wu, Linquan, Wenjun, Liao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354767/
https://www.ncbi.nlm.nih.gov/pubmed/35921289
http://dx.doi.org/10.1080/15384047.2022.2094666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354767/
https://www.ncbi.nlm.nih.gov/pubmed/35921289
http://dx.doi.org/10.1080/15384047.2022.2094666

Ejemplares similares